Showing results (631-640 of 835) with videos related to
Sort By:
Pageof 84
Journal of the American College of Surgeons|April 28, 2010
Long-term follow-up of abdominal wall reconstruction after planned ventral hernia: a 15-year experienceJennifer M DiCocco, Louis J Magnotti, Katrina P Emmett, et al.Scientific Data|March 29, 2017
Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.Scientific Reports|February 3, 2022
Advanced sequencing approaches detected insertions of viral and human origin in the viral genome of chronic hepatitis E virus patientsC-Patrick Papp, Paula Biedermann, Dominik Harms, et al.Journal of the American Chemical Society|December 6, 2019
Insight into the Mechanisms Driving the Self-Assembly of Functional Interfaces: Moving from Lipids to Charged Amphiphilic OligomersAzhad U Chowdhury, Graham J Taylor, Vera Bocharova, et al.Hepatology (Baltimore, Md.)|February 24, 2006
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33Alexander W Tarr, Ania M Owsianka, Judith M Timms, et al.Scientific Data|December 6, 2017
Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.The Journal of Pain|September 26, 2017
Daily Opioid Use Fluctuates as a Function of Pain, Catastrophizing, and Affect in Patients With Sickle Cell Disease: An Electronic Daily Diary AnalysisPatrick H Finan, C Patrick Carroll, Gyasi Moscou-Jackson, et al.Pediatric Blood & Cancer|April 11, 2007
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.Pediatric Blood & Cancer|February 23, 2008
Initial testing (stage 1) of sunitinib by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.Experimental Cell Research|April 8, 2015
Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentrationMichael A Sheard, Matthew V Ghent, Daniel J Cabral, et al.Pageof 84